Ascendis Pharma A/S (ASND) Social Stream
ASCENDIS PHARMA A (ASND) Price Targets From Analysts
Use the tables below to see what analysts covering ASCENDIS PHARMA A think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-11 | 8 | $216 | $169 | $195.222 | $137.1 | 42.39% |
| 2021-11-15 | 8 | $216 | $169 | $196.666 | $137.1 | 43.45% |
| 2021-11-18 | 9 | $216 | $169 | $196.666 | $137.1 | 43.45% |
| 2021-11-22 | 9 | $216 | $169 | $195.888 | $137.1 | 42.88% |
| 2021-12-08 | 10 | $214 | $169 | $191.444 | $137.1 | 39.64% |
| 2022-01-07 | 10 | $214 | $136 | $185.9 | $137.1 | 35.59% |
| 2022-01-13 | 10 | $214 | $136 | $185.4 | $137.1 | 35.23% |
| 2022-01-25 | 10 | $214 | $136 | $185.7 | $137.1 | 35.45% |
| 2022-01-26 | 10 | $214 | $136 | $185.5 | $137.1 | 35.3% |
| 2022-02-14 | 10 | $214 | $136 | $184.09 | $137.1 | 34.27% |
| 2022-02-23 | 10 | $214 | $128 | $178.545 | $137.1 | 30.23% |
| 2022-03-01 | 11 | $214 | $128 | $179.25 | $137.1 | 30.74% |
| 2022-03-09 | 11 | $214 | $117 | $175 | $137.1 | 27.64% |
| 2022-03-15 | 10 | $230 | $117 | $177.666 | $137.1 | 29.59% |
| 2022-03-22 | 10 | $230 | $117 | $179.083 | $137.1 | 30.62% |
| 2022-03-28 | 10 | $230 | $136 | $182.916 | $137.1 | 33.42% |
| 2022-03-29 | 10 | $230 | $136 | $182.666 | $137.1 | 33.24% |
| 2022-04-13 | 10 | $230.001 | $136 | $182.666 | $137.1 | 33.24% |
| 2022-04-20 | 10 | $230.001 | $136 | $182.333 | $137.1 | 32.99% |
| 2022-05-11 | 10 | $230.001 | $136 | $180.75 | $137.1 | 31.84% |
| 2022-05-12 | 10 | $210 | $127 | $170.75 | $137.1 | 24.54% |
| 2022-05-13 | 10 | $196 | $84 | $152.818 | $137.1 | 11.46% |
| 2022-05-31 | 10 | $180 | $84 | $148.5 | $137.1 | 8.32% |
| 2022-07-25 | 10 | $180 | $84 | $148 | $137.1 | 7.95% |
| 2022-08-13 | 10 | $184 | $84 | $146.3 | $137.1 | 6.71% |
| 2022-08-30 | 11 | $184 | $84 | $148.09 | $137.1 | 8.02% |
| 2022-09-17 | 11 | $176 | $84 | $144.5 | $137.1 | 5.4% |
| 2022-10-12 | 11 | $172 | $84 | $144.1 | $137.1 | 5.11% |
| 2022-10-21 | 12 | $172 | $84 | $144.3 | $137.1 | 5.25% |
| 2022-10-27 | 12 | $182 | $84 | $147.727 | $137.1 | 7.75% |
| 2022-10-31 | 12 | $182 | $84 | $149.272 | $137.1 | 8.88% |
| 2022-11-03 | 12 | $182 | $84 | $150.272 | $137.1 | 9.61% |
| 2022-11-04 | 12 | $182 | $93.2 | $151.563 | $137.1 | 10.55% |
| 2022-11-14 | 12 | $182 | $93.2 | $152.472 | $137.1 | 11.21% |
| 2022-11-16 | 12 | $182 | $93.2 | $150.654 | $137.1 | 9.89% |
| 2022-11-17 | 12 | $182 | $93.2 | $151.29 | $137.1 | 10.35% |
| 2023-01-13 | 12 | $182 | $93.2 | $152.018 | $137.1 | 10.88% |
| 2023-01-17 | 12 | $182 | $93.2 | $153.381 | $137.1 | 11.88% |
| 2023-01-26 | 12 | $182 | $104.31 | $154.573 | $137.1 | 12.74% |
| 2023-02-16 | 12 | $182 | $104.31 | $154.937 | $137.1 | 13.01% |
| 2023-02-17 | 12 | $182 | $110 | $155 | $137.1 | 13.06% |
| 2023-02-21 | 12 | $182 | $117.26 | $155.932 | $137.1 | 13.74% |
| 2023-03-06 | 12 | $182 | $117.26 | $156.114 | $137.1 | 13.87% |
| 2023-04-03 | 12 | $195 | $117.26 | $158.75 | $137.1 | 15.79% |
| 2023-04-04 | 12 | $195 | $92 | $155.114 | $137.1 | 13.14% |
| 2023-04-10 | 12 | $195 | $92 | $149.226 | $137.1 | 8.84% |
| 2023-04-24 | 12 | $195 | $92 | $147.426 | $137.1 | 7.53% |
| 2023-04-27 | 12 | $195 | $92 | $143.426 | $137.1 | 4.61% |
| 2023-04-28 | 12 | $195 | $92 | $142.226 | $137.1 | 3.74% |
| 2023-05-01 | 12 | $195 | $92 | $141.7 | $137.1 | 3.36% |
| 2023-05-02 | 12 | $195 | $92 | $138.2 | $137.1 | 0.8% |
| 2023-05-08 | 12 | $186 | $92 | $137.3 | $137.1 | 0.15% |
| 2023-05-10 | 12 | $186 | $105 | $138.8 | $137.1 | 1.24% |
| 2023-06-07 | 12 | $187 | $105 | $138.9 | $137.1 | 1.31% |
| 2023-07-31 | 11 | $187 | $105 | $139.888 | $137.1 | 2.03% |
| 2023-09-06 | 11 | $187 | $105 | $136.625 | $137.1 | -0.35% |
| 2023-09-07 | 11 | $192 | $110 | $135.25 | $137.1 | -1.35% |
| 2023-10-17 | 11 | $192 | $110 | $135.5 | $137.1 | -1.17% |
| 2023-11-08 | 12 | $192 | $110 | $136 | $137.1 | -0.8% |
| 2023-11-09 | 12 | $192 | $110 | $136.666 | $137.1 | -0.32% |
| 2023-11-20 | 12 | $192 | $110 | $137.666 | $137.1 | 0.41% |
| 2023-12-12 | 12 | $200 | $110 | $138.555 | $137.1 | 1.06% |
| 2023-12-20 | 13 | $202 | $116 | $146.4 | $137.1 | 6.78% |
The Trend in the Analyst Price Target
ASND's average price target has moved down $21.65 over the prior 43 months.
ASND reports an average of 54.46% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-10 | 12 | 195 | 92 | 149.226 | 73.92 | 101.88% |
| 2023-04-24 | 12 | 195 | 92 | 143.426 | 79.77 | 79.8% |
| 2023-04-27 | 12 | 195 | 92 | 143.426 | 76.98 | 86.32% |
| 2023-06-07 | 11 | 187 | 105 | 139.888 | 90.40 | 54.74% |
| 2023-06-07 | 12 | 187 | 105 | 138.900 | 90.40 | 53.65% |
ASND Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.46 | 10 | 0 | 3 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
Over the past 31 weeks, ASND's average broker recommendation rating improved by 0.04.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ASND as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ASCENDIS PHARMA A's average analyst price target is greater than 6861.73% of them.
- In terms of how ASCENDIS PHARMA A fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 6341.38% of that group.
- ASND has a higher upside potential (average analyst target price relative to current price) than 1814.92% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, ASCENDIS PHARMA A's variance in analysts' estimates is lower than -4943.67% of them.
Stocks similar to ASCENDIS PHARMA A in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RVNC, TBPH, and PRTA.
View All Top Stocks by Price Target
Is ASND a Buy, Hold or Sell? See the POWR Ratings now!